{"name": "Ablexis",
 "permalink": "ablexis",
 "crunchbase_url": "http://www.crunchbase.com/company/ablexis",
 "homepage_url": "http://www.ablexis.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "ablexis",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@ablexis.com",
 "phone_number": "(415) 978-2177",
 "description": "",
 "created_at": "Tue Jun 08 01:14:05 UTC 2010",
 "updated_at": "Thu Apr 04 06:24:28 UTC 2013",
 "overview": "\u003Cp\u003EAblexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, was founded in December 2009, based on technology principles established by its subsidiary, Aliva Biopharmaceuticals, Inc.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       30],
      "assets/images/resized/0008/9828/89828v1-max-150x150.jpg"],
     [[223,
       46],
      "assets/images/resized/0008/9828/89828v1-max-250x250.jpg"],
     [[223,
       46],
      "assets/images/resized/0008/9828/89828v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Larry",
      "last_name": "Green",
      "permalink": "larry-green",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$12M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/ablexis-llc-series-a-12m/",
    "source_description": "Ablexis, LLC: Series A $12M",
    "raised_amount": 12000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 6,
    "funded_day": 4,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Third Rock Ventures",
         "permalink": "third-rock-ventures-2",
         "image":
          {"available_sizes":
            [[[150,
               78],
              "assets/images/resized/0005/0700/50700v1-max-150x150.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-250x250.png"],
             [[205,
               107],
              "assets/images/resized/0005/0700/50700v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pfizer Venture Investments",
         "permalink": "pfizer-venture-investments",
         "image":
          {"available_sizes":
            [[[150,
               97],
              "assets/images/resized/0025/2881/252881v1-max-150x150.png"],
             [[200,
               130],
              "assets/images/resized/0025/2881/252881v1-max-250x250.png"],
             [[200,
               130],
              "assets/images/resized/0025/2881/252881v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        79],
       "assets/images/resized/0008/9829/89829v1-max-150x150.jpg"],
      [[250,
        132],
       "assets/images/resized/0008/9829/89829v1-max-250x250.jpg"],
      [[450,
        238],
       "assets/images/resized/0008/9829/89829v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}